Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman

Louis G. Lange, M.D., Ph.D. appointed as Lead Independent Director SAN FRANCISCO, Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing in... Biopharmaceuticals, Personnel Audentes Therapeutics, Myotubular Myopathy, Crigler-Najjar syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news